Assyro AI
FDA 483 Database

FDA Form 483s Issued in November 2023

Every published Form FDA 483 issued in November 2023, drawn from the FDA OII FOIA Electronic Reading Room. Each row links to the FDA source record.

8

Published 483s in November 2023

8

Distinct firms

Form 483s issued in November 2023

Daizo CorporationFDA
FEI
3008470621
Issued
Nov 6, 2023
Establishment
OTC Drug Manufacturer
Location
Japan
Takeda Pharmaceutical Company, LimitedFDA
FEI
3004664162
Issued
Nov 6, 2023
Establishment
Human Drug Manufacturer
Location
Japan
Nanchang Anobri Pharmaceutical Co., Ltd.FDA
FEI
3023765884
Issued
Nov 21, 2023
Establishment
Finished Pharmaceutical Manufacturer
Location
China
C&T Dream Co., Ltd.FDA
FEI
3012668529
Issued
Nov 10, 2023
Establishment
Finished Pharmaceutical Manufacturer
Location
Republic of Korea
Contract Pharmaceuticals Limited CanadaFDA
FEI
3001581899
Issued
Nov 3, 2023
Establishment
Finished Pharmaceutical Manufacturer
Location
Canada
Catalent Indiana, LLCFDA
FEI
3005949964
Issued
Nov 15, 2023
Establishment
Manufacturer
Location
Indiana, United States
Wedgewood Connect, LLCFDA
FEI
3003434972
Issued
Nov 17, 2023
Establishment
Outsourcing Facility
Location
California, United States
Hybrid Pharma LLCFDA
FEI
3011319445
Issued
Nov 9, 2023
Establishment
Outsourcing Facility
Location
Florida, United States

Other months in 2023

Back to the FDA 483 Database